Pulse Biosciences Inc.

NASDAQ: PLSE · Real-Time Price · USD
17.41
0.10 (0.58%)
At close: Aug 15, 2025, 10:02 AM

Pulse Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-53.59M -42.21M -58.51M -63.66M
Depreciation & Amortization
1.18M 1.21M 1.35M 1.15M
Stock-Based Compensation
13.59M 7.18M 5.19M 14.6M
Other Working Capital
2.63M 396K 221K -1.47M
Other Non-Cash Items
6K 13K 8.66M 13K
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
2.47M 768K -3.72M -6.2M
Operating Cash Flow
-36.34M -33.04M -47.01M -54.1M
Capital Expenditures
-125K -121K -401K -437K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a 8M
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
-125K -121K -401K 7.56M
Debt Repayment
n/a n/a 65M 407K
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
50.49M -6K 75K 62.51M
Financial Cash Flow
110.14M 16.39M 79.94M 62.69M
Net Cash Flow
73.67M -16.77M 32.52M 16.15M
Free Cash Flow
-36.47M -33.16M -47.41M -54.53M